GLP1R and type 2 diabetes mellitus: Recent research has identified GLP1R (glucagon like peptide 1 receptor) agonists, which are currently in clinical use for the treatment of T2D, as modulators of autophagy in several different tissues [24], including β-cells [18,25,26].